IRVINE, Calif.,
Aug. 28,
2023 /PRNewswire/ -- Edwards Lifesciences Corporation
(NYSE: EW) today announced it is scheduled to present at the 2023
Wells Fargo Healthcare Conference on Thursday, September 7, 2023.
Bernard Zovighian, chief executive officer, and
Scott B. Ullem, chief financial
officer, are scheduled to speak to conference attendees at
11:00 a.m. ET. A live webcast of the
presentation will be available to all interested parties on the
Edwards Lifesciences investor relations website at
http://ir.edwards.com/. An archived version of the webcast will be
available later that day on the Edwards investor relations
website.
About Edwards Lifesciences
Edwards Lifesciences
is the global leader of patient-focused innovations for structural
heart disease and critical care monitoring. We are driven by a
passion for patients, dedicated to improving and enhancing lives
through partnerships with clinicians and stakeholders across the
global healthcare landscape. For more information, visit
Edwards.com and follow us on Facebook, Instagram, LinkedIn, Twitter
and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation. All other
trademarks are the property of their respective owners.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-2023-wells-fargo-healthcare-conference-301910480.html
SOURCE Edwards Lifesciences Corporation